Schizophrenia Clinical Trials in Houston

Showing 61-67 of 67 trials

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

NCT01376076

This study will evaluate the effects of sequential multiple dose regimens of cariprazine on cardiac repolarization in patients with schizophrenia.

Schizophrenia

Forest Laboratories129 participantsStarted Jun 2011

Glendale, California, United States • Long Beach, California, United States • Willingboro, New Jersey, United States +1 more locations

COMPLETEDPHASE3< 1 mile

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

NCT00347425

The study will evaluate the safety and tolerability of switching subjects with schizophrenia or schizoaffective disorder from their existing antipsychotic medication to Bifeprunox.

Schizophrenia and Schizoaffective Disorder

Solvay Pharmaceuticals286 participantsStarted Dec 2006

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Anaheim, California, United States +119 more locations

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Schizophrenia Trials in Other Cities

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Other Conditions in Houston